NOX4 silencing or ROS inhibitor (NAC or DPI) treatment inhibited the increase in ROS, caspase-3 activity, cytotoxicity, and the PERK-ATF4-CHOP signaling pathway in 8-shogaol-treated gastric cancer cells. The gene discussed is ATF4; the disease is gastric cancer.